T1	PROC 49 77	estudio de extensión abierto
T2	LIVB 83 92	pacientes
#1	AnnotatorNotes T2	C0030705; Patients; Patient or Disabled Group
T3	PROC 174 220	Estudio de extensión abierta (OLE) de fase III
T4	PROC 226 246	evaluar la seguridad
T5	PROC 253 279	administración intravítrea
T6	Route 268 279	intravítrea
T7	CHEM 283 301	avacincaptad pegol
T8	CHEM 303 331	inhibidor del complemento C5
T9	LIVB 336 345	pacientes
#2	AnnotatorNotes T9	C0030705; Patients; Patient or Disabled Group
T10	DISO 350 368	atrofia geográfica
#3	AnnotatorNotes T10	C1536085; Geographic Atrophy; Disease or Syndrome
T11	PROC 403 422	estudio de fase III
T12	DISO 465 484	Atrofia greográfica
T13	DISO 511 529	Atrofia geográfica
#4	AnnotatorNotes T13	C1536085; Geographic Atrophy; Disease or Syndrome
T14	LIVB 556 588	Pacientes masculinos o femeninos
T15	Age 592 605	50 años o más
T16	PROC 606 620	diagnosticados
#5	AnnotatorNotes T16	C0011900; Diagnosis; Diagnostic Procedure
T17	DISO 625 627	AG
T18	ANAT 651 656	fóvea
#6	AnnotatorNotes T18	C0450290; Entire fovea centralis; Body Part, Organ, or Organ Component | C0836913; Fossa; Body Space or Junction
T19	PROC 712 718	visita
T20	Date 723 729	Mes 24
T21	PROC 736 747	tratamiento
#7	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	PROC 797 808	tratamiento
#8	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	CHEM 813 831	avacincaptad pegol
T24	CHEM 834 838	Sham
T25	PROC 883 892	protocolo
#9	AnnotatorNotes T25	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T26	LIVB 963 972	pacientes
#10	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	PROC 1001 1037	consentimiento informado por escrito
T28	PROC 1129 1136	visitas
T29	Duration 1156 1168	los 18 meses
T30	LIVB 1211 1220	pacientes
#11	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Neg_cue 1221 1223	no
T32	Negated 1230 1255	elegibles para el estudio
T33	LIVB 1266 1274	paciente
#12	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	Neg_cue 1275 1277	no
T35	Negated 1278 1297	completó el estudio
T36	PROC 1326 1332	visita
T37	Date 1337 1343	mes 24
T38	PROC 1347 1358	tratamiento
#13	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T39	CHEM 1379 1397	avacincaptad pegol
T40	CHEM 1400 1404	Sham
T41	LIVB 1414 1423	pacientes
#14	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	PROC 1441 1458	retiró el fármaco
T43	DISO 1498 1500	EA
#15	AnnotatorNotes T43	C0002395; Alzheimer's Disease; Disease or Syndrome | C0003507; Aortic Valve Stenosis; Disease or Syndrome | C0038013; Ankylosing spondylitis; Disease or Syndrome | C0947926; Alzheimer's disease (incl subtypes); Mental or Behavioral Dysfunction
T44	Neg_cue 1501 1503	no
T45	Negated 1508 1517	elegibles
T46	LIVB 1523 1532	pacientes
#16	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	PROC 1550 1581	retuvo temporalmente el fármaco
T48	DISO 1606 1608	AA
#17	AnnotatorNotes T48	C0000727; Abdomen, Acute; Sign or Symptom | C0002874; Aplastic Anemia; Disease or Syndrome | C0003486; Aortic Aneurysm; Disease or Syndrome | C0004031; Aspergillosis, Allergic Bronchopulmonary; Disease or Syndrome | C0085693; Acute appendicitis NOS (disorder); Disease or Syndrome | C0221014; Reactive systemic amyloidosis; Disease or Syndrome
T49	PROC 1611 1625	cirugía ocular
#18	AnnotatorNotes T49	C0395020; Surgical procedure on eye proper; Therapeutic or Preventive Procedure
T50	PROC 1641 1650	revisados
T51	LIVB 1704 1712	paciente
#19	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Neg_cue 1713 1715	no
T53	Negated 1719 1731	inscribió en
T54	Duration 1785 1792	90 días
T55	LIVB 1797 1818	Pacientes embarazadas
T56	LIVB 1821 1830	lactantes
#20	AnnotatorNotes T56	C0021270; Infant; Age Group
T57	Negated 1737 1747	ensayo OLE
T58	PROC 1737 1747	ensayo OLE
T59	PROC 1048 1058	ensayo OLE
T60	Observation 97 131	completaron previamente el estudio
T61	Observation 377 422	completado previamente el estudio de fase III
T62	CONC 628 634	dentro
T63	CONC 639 656	fuera de la fóvea
T64	Observation 661 683	completaron el estudio
T65	Observation 1068 1078	participar
T66	Observation 1105 1113	regresar
T67	Observation 1230 1255	elegibles para el estudio
T68	Observation 1278 1297	completó el estudio
T69	Quantifier_or_Qualifier 1471 1490	de forma permanente
T70	Observation 1508 1517	elegibles
T71	Quantifier_or_Qualifier 1626 1634	electiva
T72	Patient 83 92	pacientes
T73	Patient 336 345	pacientes
T74	History_of 403 422	estudio de fase III
T75	Patient 556 588	Pacientes masculinos o femeninos
T76	History_of 676 683	estudio
T77	History_of 797 808	tratamiento
T78	History_of 813 831	avacincaptad pegol
T79	History_of 834 838	Sham
T80	Patient 963 972	pacientes
T81	Patient 1211 1220	pacientes
T82	Patient 1266 1274	paciente
T83	Patient 1414 1423	pacientes
T84	Patient 1523 1532	pacientes
T85	Future 1641 1650	revisados
T86	Patient 1704 1712	paciente
T87	Patient 1797 1818	Pacientes embarazadas
T88	Patient 1821 1830	lactantes
T89	Future 1230 1255	elegibles para el estudio
